Evidence map›Paper›PMID 8932378›Full record

ArticleNucleic acids research1996

Stability of an inverted repeat in a human fibrosarcoma cell.

P R Kramer, J R Stringer, R R Sinden

Open access · bronzeAbstract read
In one paragraph

Article in Nucleic acids research, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. The excess of small inverted repeats in prokaryotes.Journal of molecular evolution · 2008
    Article
  4. C1 inhibitor gene sequence facilitates frameshift mutations.Molecular medicine (Cambridge, Mass.) · 1998
    Article
  5. The SbcCD nuclease of Escherichia coli is a structural maintenance of chromosomes (SMC) family protein that cleaves hairpin DNA.Proceedings of the National Academy of Sciences of the United States of America · 1998
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

P R KramerDepartment of Biochemistry and Biophysics, Texas A&M University, Houston 77030-3303, USA.
J R Stringer
R R Sinden
Texas A&M University · US

Funding

TUMOR SUPPRESSOR HETEROZYGOTES AS GENOTOXICANT REPORTERSP01ES005652 · NIEHS · UNIVERSITY OF CINCINNATI · PI STAMBROOK, PETER J · 1991 to 2000
$1.2M
NIEHS NIH HHS P01 ES 05652
6 · The paper itself

Abstract

Deletions and rearrangements of DNA sequences within the genome of human cells result in mutations associated with human disease. We have developed a selection system involving a neo gene containing a DNA sequence inserted into the NcoI site that can be used to quantitatively assay deletion of this sequence from the chromosome. The spontaneous deletion from the neo gene of a 122 bp inverted repeat occurred at a rate of 2.1 x 10(-8) to <3.1 x 10(-9) revertants/cell/generation in three different cell lines. Deletion of the 122 bp inverted repeat occurred between 6 bp flanking direct repeats. Spontaneous deletion of a 122 bp non-palindromic DNA sequence flanked by direct repeats was not observed, indicating a rate of deletion of <3.1 x 10(-9) revertants/cell/generation. This result demonstrates that a 122 bp inverted repeat can exhibit a low level of instability in some locations in the chromosome of a human cell line.

Indexed as

Repetitive Sequences, Nucleic AcidBase SequenceCell Line, TransformedChromosome InversionDNA, RecombinantDrug ResistanceFibrosarcomaHumansMolecular Sequence DataMutagenesisNeomycinPlasmidsRestriction MappingSequence DeletionTumor Cells, CulturedDNA, RecombinantNeomycin

Identifiers

PMID8932378
PMCPMC146229
OpenAlexW2134507402

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.